Global Drug of Abuse (DOA) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR062413959

Publication Date:

June 26, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Drug of Abuse (DOA) Testing market size was valued at USD 6504 million in 2023 and is forecast to a readjusted size of USD 10110 million by 2030 with a CAGR of 6.5% during review period.
The drug of abuse test is听an immunoassay based on the principle of competitive binding.听
North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
This report includes an overview of the development of the Drug of Abuse (DOA) Testing industry chain, the market status of Hospitals (Urine, Saliva), Laboratories (Urine, Saliva), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drug of Abuse (DOA) Testing.
Regionally, the report analyzes the Drug of Abuse (DOA) Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drug of Abuse (DOA) Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Drug of Abuse (DOA) Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drug of Abuse (DOA) Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Urine, Saliva).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drug of Abuse (DOA) Testing market.
Regional Analysis: The report involves examining the Drug of Abuse (DOA) Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drug of Abuse (DOA) Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Drug of Abuse (DOA) Testing:
Company Analysis: Report covers individual Drug of Abuse (DOA) Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drug of Abuse (DOA) Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Laboratories).
Technology Analysis: Report covers specific technologies relevant to Drug of Abuse (DOA) Testing. It assesses the current state, advancements, and potential future developments in Drug of Abuse (DOA) Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drug of Abuse (DOA) Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Drug of Abuse (DOA) Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Urine
Saliva
Hair
Others
Market segment by Application
Hospitals
Laboratories
Workplace
At-Home
Others
Market segment by players, this report covers
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug of Abuse (DOA) Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug of Abuse (DOA) Testing, with revenue, gross margin and global market share of Drug of Abuse (DOA) Testing from 2019 to 2024.
Chapter 3, the Drug of Abuse (DOA) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Drug of Abuse (DOA) Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug of Abuse (DOA) Testing.
Chapter 13, to describe Drug of Abuse (DOA) Testing research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope of Drug of Abuse (DOA) Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug of Abuse (DOA) Testing by Type
1.3.1 Overview: Global Drug of Abuse (DOA) Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Drug of Abuse (DOA) Testing Consumption Value Market Share by Type in 2023
1.3.3 Urine
1.3.4 Saliva
1.3.5 Hair
1.3.6 Others
1.4 Global Drug of Abuse (DOA) Testing Market by Application
1.4.1 Overview: Global Drug of Abuse (DOA) Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Laboratories
1.4.4 Workplace
1.4.5 At-Home
1.4.6 Others
1.5 Global Drug of Abuse (DOA) Testing Market Size & Forecast
1.6 Global Drug of Abuse (DOA) Testing Market Size and Forecast by Region
1.6.1 Global Drug of Abuse (DOA) Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Drug of Abuse (DOA) Testing Market Size by Region, (2019-2030)
1.6.3 North America Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
1.6.6 South America Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Drug of Abuse (DOA) Testing Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Siemens
2.1.1 Siemens Details
2.1.2 Siemens Major Business
2.1.3 Siemens Drug of Abuse (DOA) Testing Product and Solutions
2.1.4 Siemens Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Siemens Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Drug of Abuse (DOA) Testing Product and Solutions
2.2.4 Merck Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Drug of Abuse (DOA) Testing Product and Solutions
2.3.4 Roche Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Roche Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Product and Solutions
2.4.4 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Bio-Rad
2.5.1 Bio-Rad Details
2.5.2 Bio-Rad Major Business
2.5.3 Bio-Rad Drug of Abuse (DOA) Testing Product and Solutions
2.5.4 Bio-Rad Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bio-Rad Recent Developments and Future Plans
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Drug of Abuse (DOA) Testing Product and Solutions
2.6.4 Abbott Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abbott Recent Developments and Future Plans
2.7 Quest Diagnostics
2.7.1 Quest Diagnostics Details
2.7.2 Quest Diagnostics Major Business
2.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Product and Solutions
2.7.4 Quest Diagnostics Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Quest Diagnostics Recent Developments and Future Plans
2.8 Psychemedics
2.8.1 Psychemedics Details
2.8.2 Psychemedics Major Business
2.8.3 Psychemedics Drug of Abuse (DOA) Testing Product and Solutions
2.8.4 Psychemedics Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Psychemedics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Drug of Abuse (DOA) Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Drug of Abuse (DOA) Testing by Company Revenue
3.2.2 Top 3 Drug of Abuse (DOA) Testing Players Market Share in 2023
3.2.3 Top 6 Drug of Abuse (DOA) Testing Players Market Share in 2023
3.3 Drug of Abuse (DOA) Testing Market: Overall Company Footprint Analysis
3.3.1 Drug of Abuse (DOA) Testing Market: Region Footprint
3.3.2 Drug of Abuse (DOA) Testing Market: Company Product Type Footprint
3.3.3 Drug of Abuse (DOA) Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Drug of Abuse (DOA) Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Drug of Abuse (DOA) Testing Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Drug of Abuse (DOA) Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Drug of Abuse (DOA) Testing Market Forecast by Application (2025-2030)
6 North America
6.1 North America Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
6.2 North America Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
6.3 North America Drug of Abuse (DOA) Testing Market Size by Country
6.3.1 North America Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2030)
6.3.2 United States Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
7.2 Europe Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
7.3 Europe Drug of Abuse (DOA) Testing Market Size by Country
7.3.1 Europe Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7.3.3 France Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region
8.3.1 Asia-Pacific Drug of Abuse (DOA) Testing Consumption Value by Region (2019-2030)
8.3.2 China Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.5 India Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
9 South America
9.1 South America Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
9.2 South America Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
9.3 South America Drug of Abuse (DOA) Testing Market Size by Country
9.3.1 South America Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Drug of Abuse (DOA) Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Drug of Abuse (DOA) Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country
10.3.1 Middle East & Africa Drug of Abuse (DOA) Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Drug of Abuse (DOA) Testing Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Drug of Abuse (DOA) Testing Market Drivers
11.2 Drug of Abuse (DOA) Testing Market Restraints
11.3 Drug of Abuse (DOA) Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Drug of Abuse (DOA) Testing Industry Chain
12.2 Drug of Abuse (DOA) Testing Upstream Analysis
12.3 Drug of Abuse (DOA) Testing Midstream Analysis
12.4 Drug of Abuse (DOA) Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂